Elastic vesicles of sumatriptan succinate for transdermal administration: characterization and in vitro permeation studies

被引:14
作者
Balaguer-Fernandez, Cristina [1 ]
Femenia-Font, Andres [1 ]
Merino, Virginia [2 ]
Cordoba-Diaz, Damian [3 ]
Elorza-Barroeta, Maria A. [4 ]
Lopez-Castellano, Alicia [1 ]
Cordoba-Diaz, Manuel [3 ]
机构
[1] Univ CEU Cardenal Herrera, Dept Fisiol Farmacol & Toxicol, Fac Ciencias Salud, Moncada 46113, Spain
[2] Univ Valencia, Inst Reconocimiento Mol & Desarrollo Tecnol, Ctr Mixto,Univ Politecn Valencia, Dept Farm & Tecnol Farmaceut,Fac Farm, Burjassot, Spain
[3] Univ Complutense Madrid, Fac Farm, Dept Farm & Tecnol Farmaceut, Madrid, Spain
[4] Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, Madrid, Spain
关键词
Ultradeformable liposomes; skin permeation; particle size; polydispersity index; elasticity; DELIVERY; MIGRAINE; SKIN;
D O I
10.3109/08982101003736002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elastic liposomes, including sumatriptan succinate, were prepared for their transdermal administration. Lipid vesicles containing 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or l-a-phosphatidylcholine dilauroyl (DLPC) phospholipids were characterized for various parameters, including size, particle-size distribution (i.e., polydispersity index), and elasticity. In vitro transdermal experiments for the study of the skin penetration of sumatriptan succinate contained in liposomes were performed by using flow-through diffusion cells. The diameter of sumatriptan liposomes with different lipid compositions varied between 279 and 282 nm, and the polydispersity index value for the size distribution of liposomal formulations was <0.5. DLPC vesicles proved to be more elastic and provided a higher sumatriptan transdermal flux than vesicles formulated with DOPC phospolipid.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 15 条
[1]   Current options for the prevention and treatment of migraine [J].
Adelman, JU ;
Adelman, RD .
CLINICAL THERAPEUTICS, 2001, 23 (06) :772-788
[2]   Sumatriptan succinate transdermal delivery systems for the treatment of migraine [J].
Balaguer-Fernandez, C. ;
Femenia-Font, A. ;
Del Rio-Sancho, S. ;
Merino, V. ;
Lopez-Castellano, A. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (06) :2102-2109
[3]  
Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915
[4]   Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery [J].
Cevc, G .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1996, 13 (3-4) :257-388
[5]   Lipid vesicles and other colloids as drug carriers on the skin [J].
Cevc, G .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :675-711
[6]  
Cevc G, 1997, Expert Opin Investig Drugs, V6, P1887, DOI 10.1517/13543784.6.12.1887
[7]  
CEVC G, 2008, MODIFIED RELEASE DRU, P319
[8]  
DIAZ MC, 2000, J CONTROL RELEASE, V69, P357
[9]   Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan [J].
Femenia-Font, A. ;
Padula, C. ;
Marra, F. ;
Balacuer-Fernandez, C. ;
Merino, V. ;
Lopez-Castellano, A. ;
Nicoli, S. ;
Santi, P. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (07) :1561-1569
[10]   High-performance liquid chromatographic determination of sumatriptan after in vitro transdermal diffusion studies [J].
Femenía-Font, A ;
Merino, V ;
Rodilla, V ;
López-Castellano, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (03) :621-626